Publications by authors named "Susanna Coll"

Claim this Profile
O
On-therapy HBsAg kinetics can predict HBsAg loss after nucleos(t)ide analogues interruption in HBeAg-negative patients. The cup is half full and half empty.
Teresa Broquetas, Juan-Jose Hernandez, Montserrat Garcia-Retortillo, Lidia Canillas, Marc Puigvehí, Susanna Coll

Dig Liver Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and characteristics of hepatitis C virus-related hepatocellular carcinoma in a Spanish university hospital.
Lidia Canillas, Marçal Parcerisa, Susanna Coll, Montserrat García-Retortillo, Francesc Macià

Cancer Epidemiol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the impact of COVID-19 on liver cancer management (CERO-19).
Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, Jean-Charles Nault, Gonzalo Sapisochin, Susanna Coll

JHEP Rep· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis.
Álvaro Díaz-González, Marco Sanduzzi-Zamparelli, Leonardo G da Fonseca, Giovan G Di Costanzo, Rogerio Alves, Susanna Coll

Liver Int· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of anthropometric features on the applicability and accuracy of FibroScan (M and XL) in overweight/obese patients.
Marc Puigvehí, Teresa Broquetas, Susanna Coll, Montserrat Garcia-Retortillo, Nuria Cañete

J Gastroenterol Hepatol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF®) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years.
Marc Puigvehí, Juanjo Hernández, Teresa Broquetas, Susanna Coll, Montserrat Garcia-Retortillo

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Evaluation and treatment of the critically ill cirrhotic patient].
Javier Fernández, Carles Aracil, Elsa Solà, Germán Soriano, Maria Cinta Cardona, Susanna Coll

Gastroenterol Hepatol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-drug interactions of telaprevir and boceprevir in HCV-monoinfected and HIV/HCV-coinfected patients can modify the adherence.
Elena González-Colominas, Teresa Broquetas, Alexandra Retamero, Montserrat García-Retortillo, Nuria Cañete, Susanna Coll

Liver Int· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multidisciplinary support programme increases the efficiency of pegylated interferon alfa-2a and ribavirin in hepatitis C.
José Antonio Carrión, Elena Gonzalez-Colominas, Montserrat García-Retortillo, Nuria Cañete, Isabel Cirera, Susanna Coll

J Hepatol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites.
Silvia Montoliu, Belén Ballesté, Ramon Planas, Marco Antonio Alvarez, Mònica Rivera, Susanna Coll

Clin Gastroenterol Hepatol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in virological response to pegylated interferon and ribavirin between hepatitis C virus (HCV)-monoinfected and HCV-HIV-coinfected patients.
Cristina Tural, Josep Antón Galeras, Ramon Planas, Susanna Coll, Guillem Sirera

Antivir Ther· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history of patients hospitalized for management of cirrhotic ascites.
Ramon Planas, Silvia Montoliu, Belen Ballesté, Monica Rivera, Mireia Miquel, Susanna Coll

Clin Gastroenterol Hepatol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor response to hepatitis C virus (HCV) therapy in HIV- and HCV-coinfected patients is not due to lower adherence to treatment.
Ricard Solà, Josep Antón Galeras, Silvia Montoliu, Cristina Tural, Lluis Force, Susanna Coll

AIDS Res Hum Retroviruses· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probability of liver cancer and survival in HCV-related or alcoholic-decompensated cirrhosis. A study of 377 patients.
Ricard Solà, Marco Antonio Alvarez, Belén Ballesté, Silvia Montoliu, Mònica Rivera, Susanna Coll

Liver Int· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients.
Ramon Planas, Belén Ballesté, Marco Antonio Alvarez, Monica Rivera, Silvia Montoliu, Susanna Coll

J Hepatol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of early decrease in systemic vascular resistance after total paracentesis: influence of flow rate of ascites extraction.
Susanna Coll, Maria Carme Vila, Lluis Molina, Maria Dolores Gimenez, Carlos Guarner

Eur J Gastroenterol Hepatol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prevalence of hepatitis B and hepatitis C viruses in different counties of Catalonia, Spain: cross-sectional study].
Ricard Solà, Eva Cruz De Castro, Manuela Hombrados, Ramón Planas, Susanna Coll

Med Clin (Barc)· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis